Oncotarget

Vol 10, No 57

October 15, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 57 of Oncotarget features Figure 2, "Overall survival analysis of GLUT1, PD-L1, and histologic architecture," by Chamseddin, et al.

Table of Contents

News

Combatting PDAC with two tumor-targeting small RNAs

Combatting PDAC with two tumor-targeting small RNAs

https://doi.org/10.18632/oncotarget.27245

Andrea L. Kasinski
5892-5893
PDF  |  How to cite  |  Order a Reprint

Research Papers

Malignant ascites: a source of therapeutic protein against ovarian cancer?

Malignant ascites: a source of therapeutic protein against ovarian cancer?

https://doi.org/10.18632/oncotarget.27185

Pascale Ribaux, Aurore Britan, Gabriele Thumann, Florence Delie, Patrick Petignat,  and Marie Cohen
5894-5905
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer

Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer

https://doi.org/10.18632/oncotarget.27187

Yosuke Ooizumi, Hiroshi Katoh, Mitsuo Yokota, Masahiko Watanabe,  and Keishi Yamashita
5906-5918
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma

Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma

https://doi.org/10.18632/oncotarget.27194

Shatha Albattal, Meshael Alswailem, Yosra Moria, Hindi Al-Hindi, Majed Dasouki, Mohamed Abouelhoda, Hala Aba Alkhail, Entissar Alsuhaibani,  and Ali S. Alzahrani
5919-5931
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer

https://doi.org/10.18632/oncotarget.27219

Shiho Fukui, Kazunori Nagasaka, Yuko Miyagawa, Ryoko Kikuchi-Koike, Yoshiko Kawata, Ranka Kanda, Takayuki Ichinose, Takeru Sugihara, Haruko Hiraike, Osamu Wada-Hiraike, Yuko Sasajima,  and Takuya Ayabe
5932-5948
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Germline mutations in cancer-predisposition genes in patients with biliary tract cancer

Germline mutations in cancer-predisposition genes in patients with biliary tract cancer

https://doi.org/10.18632/oncotarget.27224

Takeshi Terashima, Kumiko Umemoto, Hideaki Takahashi, Hiroko Hosoi, Erina Takai, Shunsuke Kondo, Yasunari Sakamoto, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Mitsuhito Sasaki, Masafumi Ikeda, Kazuaki Shimada, Shuichi Kaneko, Shinichi Yachida, Kokichi Sugano, Takuji Okusaka,  and Chigusa Morizane
5949-5957
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma

Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma

https://doi.org/10.18632/oncotarget.27234

Bahir H. Chamseddin, Eunice E. Lee, Jiwoong Kim, Xiaowei Zhan, Rong Yang, Kathleen M. Murphy, Cheryl Lewis, Gregory A. Hosler, Suntrea T. Hammer,  and Richard C. Wang
5958-5969
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

https://doi.org/10.18632/oncotarget.27235

Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy,  and Siu Kwan Sze
5970-5982
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells

https://doi.org/10.18632/oncotarget.27236

Francina J. Dijk, Miriam van Dijk, Bram Dorresteijn,  and Klaske van Norren
5983-5992
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma

https://doi.org/10.18632/oncotarget.27243

Qiang Qiu, Mengyuan Li, Linyu Yang, Minghai Tang, Li Zheng, Fang Wang, Huandi Qiu, Cailing Liang, Ning Li, Dongni Yi, Yuyao Yi, Cong Pan, Shengyong Yang, Lijuan Chen,  and Yiguo Hu
5993-6005
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells

https://doi.org/10.18632/oncotarget.10298

Prachi Namjoshi, Lori Showalter, Brian J. Czerniecki,  and Gary K. Koski
6006-6020
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

Splicing regulatory factors in breast cancer hallmarks and disease progression

Splicing regulatory factors in breast cancer hallmarks and disease progression

https://doi.org/10.18632/oncotarget.27215

Esmee Koedoot, Liesanne Wolters, Bob van de Water,  and Sylvia E. Le Dévédec
6021-6037
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Case Reports

Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

https://doi.org/10.18632/oncotarget.27203

Mayank Rao, Meenakshi Bhattacharjee, Scott Shepard,  and Sigmund Hsu
6038-6042
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Corrections

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

https://doi.org/10.18632/oncotarget.27256

Stefano Sestini, Mattia Boeri, Alfonso Marchiano, Giuseppe Pelosi, Carlotta Galeone, Carla Verri, Paola Suatoni, Nicola Sverzellati, Carlo La Vecchia, Gabriella Sozzi,  and Ugo Pastorino
6043-6043
Correction  |  PDF  |  How to cite

Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis

Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis

https://doi.org/10.18632/oncotarget.27257

Haiyan Tan, Chun Zeng, Junbo Xie, Norah J. Alghamdi, Ya Song, Hongbing Zhang, Aimin Zhou,  and Di Jin
6044-6044
Correction  |  PDF  |  How to cite

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation

https://doi.org/10.18632/oncotarget.27258

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu,  and Ann Marie Pendergast
6045-6046
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC